Frontier Medicines
Frontier Medicines is a biopharmaceutical company developing chemoproteomics for drug discovery founded in 2018.
2
Funding Rounds
$155.5m
Money raised
Funding
Funding series
Funding Series Analysis
The company Frontier Medicines has raised a total of $155.5m in funding over 2 rounds.
Key Insights:
- Frontier Medicines Series B round, July 2021: $88.5m
- Frontier Medicines Series A round, June 2019: $67m
Frontier Medicines Series B round, July 2021
$88.5m
Frontier Medicines Series A round, June 2019
$67m
Industries
Frontier Medicines is active in the following industries: